PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA, USA.\', \'Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.\', \'Center for Biomedical Informatics, College of Medicine, Texas A&M University Health Science Center, Houston, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/cts.13007
?:hasPublicationType
?:journal
  • Clinical and translational science
is ?:pmid of
?:pmid
?:pmid
  • 33606912
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.669
?:rankingScore_hIndex
  • 31
is ?:relation_isRelatedTo_publication of
?:title
  • Virtual screening FDA approved drugs against multiple targets of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all